Jiedu Tongluo Tiaogan Formula Modulates Glycolipid Metabolism in Type 2 Diabetes via Pyroptosis: Network Pharmacology and In Vivo Analysis
Authors:
- 11 April 2025
- journal article
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (5) , e70077
Abstract
Type 2 diabetes mellitus (T2DM) is characterized by pancreatic β‐cell dysfunction and insulin resistance, with pyroptosis emerging as a key contributor to β‐cell loss. Jiedu Tongluo Tiaogan Formula (JTTF), a traditional Chinese medicine (TCM), has shown clinical efficacy in T2DM management, but its mechanism linking pyroptosis remains unexplored. This study integrates UPLC‐MS/MS, network pharmacology, and in vivo experiments to elucidate JTTF's anti‐diabetic mechanisms. UPLC‐MS/MS identified 441 compounds in JTTF, predominantly alkaloids, flavonoids, phenols, and terpenoids. Network pharmacology revealed JTTF's multi‐target effects on T2DM‐associated pyroptosis, particularly via the NLRP3/Caspase‐1/GSDMD pathway. In diabetic mice, JTTF dose‐dependently reduced fasting blood glucose, insulin resistance, and dyslipidemia, while restoring pancreatic β‐cell morphology. Mechanistically, JTTF suppressed NLRP3 inflammasome activation, downregulated Caspase‐1 and GSDMD expression, and attenuated IL‐1β/IL‐18 release. Notably, this study provides the first evidence of JTTF's anti‐pyroptotic effects in T2DM, highlighting its unique ability to modulate glycolipid metabolism and inflammatory cell death concurrently. These findings underscore JTTF's translational promise for preserving β‐cell function and suggest future exploration of non‐classical pyroptosis pathways. Our work bridges traditional medicine and molecular pharmacology, paving the way for clinical trials and integrative T2DM therapies.Keywords
Funding Information
- Natural Science Foundation of Jilin Province (20210101218JC)
This publication has 51 references indexed in Scilit:
- N6‐methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE‐RAGE pathwayEnvironmental Toxicology, 2023
- Targeting NLRP3 inflammasome as a chief instigator of obesity, contributing to local adipose tissue inflammation and insulin resistanceEnvironmental Science and Pollution Research, 2021
- Streptozotocin‐Induced Diabetic Models in Mice and RatsCurrent Protocols, 2021
- Research progress on classical traditional Chinese medicine formula Liuwei Dihuang pills in the treatment of type 2 diabetesBiomedicine & Pharmacotherapy, 2020
- Searching Online Mendelian Inheritance in Man (OMIM): A Knowledgebase of Human Genes and Genetic PhenotypesCurrent Protocols in Bioinformatics, 2017
- BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathwayEnvironmental Toxicology and Pharmacology, 2015
- CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networksBioSystems, 2015
- Pancreatic β Cell Dedifferentiation in Diabetes and Redifferentiation following Insulin TherapyCell Metabolism, 2014
- TIGAR, a p53-Inducible Regulator of Glycolysis and ApoptosisCell, 2006
- Design and synthesis of novel antidiabetic agentsArchives of Pharmacal Research, 2005